|
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2008) |
Microphotograph of a histological section of human skin prepared for
direct immunofluorescence using an anti-IgA antibody. The skin is from a patient with Henoch-Schonlein purpura: IgA deposits are found in the walls of small superficial capillaries (yellow arrows). The pale wavy green area on top is the epidermis, the bottom fibrous area is the dermis.
Immunofluorescence is a technique used for light microscopy with a fluorescence microscope and is used primarily on microbiological samples. This technique uses the specificity of antibodies to their antigen to target fluorescent dyes to specific biomolecule targets within a cell, and therefore allows visualisation of the distribution of the target molecule through the sample. Immunofluorescence is a widely used example of immunostaining and is a specific example of immunohistochemistry that makes use of fluorophores to visualise the location of the antibodies.[1]
Immunofluorescence can be used on tissue sections, cultured cell lines, or individual cells, and may be used to analyse the distribution of proteins, glycans, and small biological and non-biological molecules. Immunofluoresence can be used in combination with other, non-antibody methods of fluorescent staining, for example, use of DAPI to label DNA. Several microscope designs can be used for analysis of immunofluorescence samples; the simplest is the epifluorescence microscope, and the confocal microscope is also widely used. Various super-resolution microscope designs that are capable of much higher resolution can also be used.[2]
Contents
- 1 Types of immunofluorescence
- 1.1 Primary (direct)
- 1.2 Secondary (indirect)
- 2 Limitations
- 3 See also
- 4 References
- 5 External links
Types of immunofluorescence
Microphotograph of a histological section of human skin prepared for
direct immunofluorescence using an anti-IgG antibody. The skin is from a patient with systemic lupus erythematosus and shows IgG deposit at two different places: The first is a band-like deposit along the epidermal basement membrane ("lupus band test" is positive). The second is within the nuclei of the epidermal cells (anti-nuclear antibodies).
There are two classes of immunofluorescence techniques, primary (or direct) and secondary (or indirect).
Primary (direct)
Primary, or direct, immunofluorescence uses a single, primary antibody, chemically linked to a fluorophore. The primary antibody recognizes the target molecule (antigen) and binds to a specific region called the epitope. The attached fluorophore can be detected via fluorescent microscopy, which, depending on the messenger used, will emit a specific wavelength of light once excited.[3] Direct Immunofluorescence, although somewhat less common, has notable advantages over the secondary (indirect) procedure. The direct attachment of the messenger to the antibody reduces the number of steps in the procedure, saving time and reducing non-specific background signal. [4] This also limits the possibility of antibody cross-reactivty and possible mistakes throughout the process. However, since the number of fluorescent molecules that can be bound to the primary antibody is limited, direct immunofluorescence is substantially less sensitive than indirect immunofluorescence and may result in false negatives. Direct immunofluorescence also requires the use of much more primary antibody, which is extremely expensive, sometimes running up to $400.00/mL.
Secondary (indirect)
A fluorescent stain for actin in the smooth muscle of the skin.
Secondary, or indirect, immunofluorescence uses two antibodies; the unlabeled first (primary) antibody specifically binds the target molecule, and the secondary antibody, which carries the fluorophore, recognises the primary antibody and binds to it. Multiple secondary antibodies can bind a single primary antibody. This provides signal amplification by increasing the number of fluorophore molecules per antigen.[4] This protocol is more complex and time consuming than the primary (or direct) protocol above, but allows more flexibility because a variety of different secondary antibodies and detection techniques can be used for a given primary antibody.[4]
This protocol is possible because an antibody consists of two parts, a variable region (which recognizes the antigen) and constant region (which makes up the structure of the antibody molecule). It is important to realize that this division is artificial and in reality the antibody molecule is four polypeptide chains: two heavy chains and two light chains. A researcher can generate several primary antibodies that recognize various antigens (have different variable regions), but all share the same constant region. All these antibodies may therefore be recognized by a single secondary antibody. This saves the cost of modifying the primary antibodies to directly carry a fluorophore.
Different primary antibodies with different constant regions are typically generated by raising the antibody in different species. For example, a researcher might create primary antibodies in a goat that recognize several antigens, and then employ dye-coupled rabbit secondary antibodies that recognize the goat antibody constant region ("rabbit anti-goat" antibodies). The researcher may then create a second set of primary antibodies in a mouse that could be recognized by a separate "donkey anti-mouse" secondary antibody. This allows re-use of the difficult-to-make dye-coupled antibodies in multiple experiments.
Limitations
As with most fluorescence techniques, a significant problem with immunofluorescence is photobleaching. Loss of activity caused by photobleaching can be controlled by reducing the intensity or time-span of light exposure, by increasing the concentration of fluorophores, or by employing more robust fluorophores that are less prone to bleaching (e.g., Alexa Fluors, Seta Fluors, or DyLight Fluors).
Immunofluorescence is only limited to fixed (i.e., dead) cells when structures within the cell are to be visualized because antibodies cannot cross the cell membrane. Proteins in the supernatant or on the outside of the cell membrane can be bound by the antibodies; this allows for living cells to be stained. Depending on the fixative that is being used, proteins of interest might become cross-linked and this could result in either false positive or false negative signals due to non-specific binding.
An alternative approach is using recombinant proteins containing fluorescent protein domains, e.g., green fluorescent protein (GFP). Use of such "tagged" proteins allows determination of their localization in live cells. Even though this seems to be an elegant alternative to immunofluorescence, the cells have to be transfected or transduced with the GFP-tag, and as a consequence they become at least S1 or above organisms that require stricter security standards in a laboratory.
See also
- Immunochemistry
- Cutaneous conditions with immunofluorescence findings
References
- ^ Immunology/Immunofluorescence Protocol at Protocol-online.org
- ^ Immunofluorescence Method
- ^ http://www.dako.com/08002_03aug09_ihc_guidebook_5th_edition_chapter_10.pdf
- ^ a b c Fritschy, Jean-Marc; Härtig, Wolfgang (2001). "Immunofluorescence". ELS. doi:10.1038/npg.els.0001174. ISBN 047001590X.
External links
- Images associated with autoimmune diseases at University of Birmingham
- Immunofluorescence Staining Protocol
- Overview at Davidson College
- Immunofluorescence at the US National Library of Medicine Medical Subject Headings (MeSH)
- SynD - Automatic synapse and neurite detection in immuno-fluorescence images
|
Medicine: Pathology
|
|
| Principles of pathology |
- Disease
- Infection
- Neoplasia
- Etiology
- Pathogenesis
- Hemodynamics
- Inflammation
- Cell damage
- Wound healing
- Cellular adaptation
- Atrophy
- Hypertrophy
- Hyperplasia
- Dysplasia
- Metaplasia
- Squamous
- Glandular
- Cell death
- Necrosis
- Liquefactive necrosis
- Coagulative necrosis
- Caseous necrosis
- Fat necrosis
- Programmed cell death
- Apoptosis
- Pyknosis
- Karyorrhexis
- Karyolysis
- Accumulations:
- pigment
- Hemosiderin
- Lipochrome/Lipofuscin
- Melanin
- Steatosis
|
|
| Anatomical pathology |
- Surgical pathology
- Cytopathology
- Autopsy
- Molecular pathology
- Forensic pathology
- Oral and maxillofacial pathology
- Gross examination
- Histopathology
- Immunohistochemistry
- Electron microscopy
- Immunofluorescence
- Fluorescence in situ hybridization
|
|
| Clinical pathology |
- Clinical chemistry
- Hematopathology
- Transfusion medicine
- Medical microbiology
- Diagnostic immunology
- Immunopathology
- Enzyme assay
- Mass spectrometry
- Chromatography
- Flow cytometry
- Blood bank
- Microbiological culture
- Serology
|
|
| Specific conditions |
|
|
|
Medical test: Immunologic techniques and tests (CPT 86000–86849)
|
|
Immunologic techniques
and tests
serology/
diagnostic immunology
|
|
Immunoprecipitation
|
- Chromatin immunoprecipitation
- Immunodiffusion
- Ouchterlony double immunodiffusion
- Radial immunodiffusion
- Immunoelectrophoresis
- Counterimmunoelectrophoresis
|
|
|
Immunoassay
|
- ELISA
- ELISPOT
- Enzyme Multiplied Immunoassay Technique
- RAST test
- Radioimmunoassay
- Radiobinding assay
- Immunofluorescence
|
|
|
Agglutination
|
- Hemagglutination/Hemagglutinin
- Latex fixation test
|
|
|
Other
|
- Nephelometry
- Complement fixation test
- Immunocytochemistry
- Immunohistochemistry
- Direct fluorescent antibody
- Epitope mapping
- Skin allergy test
- Patch test
|
|
|
| Inflammation |
- C-reactive protein
- Procalcitonin
- Total complement activity
- MELISA
|
|
|
|
cell/phys/auag/auab/comp, igrc
|
|
|
|
|
|
